Brightsurf Science News and Current Science News Events
 
Email a Friend Send to a friend
Printer Friendly Print Are blood thinners post-op killers?

Are blood thinners post-op killers?

April 01, 2008

New study shows that the use of powerful anticoagulants to prevent pulmonary embolism may actually lead to more deaths after surgery

Current US guidelines for the prescription of potent anticoagulants by surgeons who perform joint replacement operations could be doing patients more harm than good, according to Dr. Nigel Sharrock and his team from the Hospital for Special Surgery in New York. They argue for a revision of the American College of Chest Physicians' guidelines, in light of their review showing that the use of powerful anticoagulants to prevent pulmonary embolism may actually lead to more deaths among patients who take these drugs. The paper1 was published in the March issue of Springer's journal Clinical Orthopaedics and Related Research.




Anticoagulants are routinely prescribed before and after total hip and knee replacement operations to reduce the risk of thrombosis, and death from pulmonary embolism in particular, as recommended by the Chest Physicians Consensus Statement. During the last decades, deaths from pulmonary embolism have fallen significantly due to a combination of advancements in anesthesia, better surgical techniques and care pre- and post-surgery, as well as a better understanding of how thrombosis develops as a result of surgery. In light of these developments, Sharrock and his team looked at whether the prescription of potent anticoagulants by surgeons who perform joint replacement operations is still warranted, as these drugs also have side effects.

The authors reviewed 20 studies among a total of just over 28,000 patients undergoing joint replacement surgery who were prescribed medication to reduce the risk of thrombosis. They compared the total number of deaths and cases of non-fatal pulmonary embolism between three frequently used prevention protocols worldwide. Patients in group A received potent anticoagulants such as low molecular weight heparin; those in group B received local spinal or epidural anesthesia, pneumatic compression and aspirin; patients in group C were prescribed slow-acting oral anticoagulants such as warfarin.

The lowest number of deaths occurred in patients in group B. Patients in groups A and C were more than twice as likely to have died as those in group B. There was no difference in the number of deaths between groups A and C. Patients in group A were also at 60-70% greater risk of non-fatal pulmonary embolism than those in group B, indicating that pulmonary embolism occurs despite the use of powerful anticoagulants.

Sharrock and colleagues conclude that "the American College of Chest Physicians should reconsider their guidelines to reflect the fact that pulmonary embolism occurs despite the use of potent anticoagulants and may, in fact, expose patients to increased mortality after surgery." In their view, the current recommendations often result in physicians feeling compelled to prescribe these anticoagulants to avoid potential litigation when, in reality, these drugs could be doing more harm than good.

Reference
1. Sharrock NE et al (2008). Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res; 466:714-721 (DOI 10.1007/s11999-007-0092-4).

Springer



Related Anticoagulant News Articles Anticoagulant News and Current Anticoagulant Events RSS Anticoagulant News and Current Anticoagulant Events RSS
Women may stop anticoagulants after blood clots
Women may safely discontinue oral anticoagulants (blood thinners) after 6 months of treatment following a first unprovoked venous blood clot (thromboembolism) if they have no or one risk factor.

New blood clot guidelines for pregnant women
New evidence-based guidelines address the prevention and management of thrombosis in key patient populations and reinforce recommendations related to the routine use of preventive therapies.

Computers as safe as medical experts for prescribing blood thinning drugs
The largest ever study into the administration of blood thinning drugs, principally Warfarin, has concluded that dosages calculated by computer are at least as safe and reliable as those provided by expert medical professionals.

Findings released from 1 of the largest percutaneous coronary intervention trials ever
A study led by Gregg W. Stone, M.D., professor of medicine at Columbia University Medical Center/NewYork-Presbyterian and chairman of the Cardiovascular Research Foundation, has shown that heart attack patients who were administered the direct thrombin inhibitor bivalirudin during primary angioplasty had a reduced rate of adverse clinical events, a lower rate of major bleeding, and a lower mortality rate than those who were treated with a regimen of heparin and glycoprotein IIb/IIIa inhibitors (GPI).

Landmark study reveals superiority of bivalirudin in heart attack patients at 30 days
The Cardiovascular Research Foundation (CRF) announced today that the New England Journal of Medicine published results of the HORIZONS AMI trial which showed the use of the anticoagulant bivalirudin following angioplasty in heart attack patients reduced net adverse clinical events by 24 percent compared to the standard treatment, as well as reduced the risk of overall mortality by 33 percent and cardiac mortality by 38 percent.

Commencement 2008: Undergrad Has Sweet Success With Invention of Artificial Golgi
An undergraduate student at Rensselaer Polytechnic Institute has learned very quickly that a spoonful of sugar really does help the medicine go down. In fact, with his invention, the sugar may actually be the medicine.

Osteoporosis drug Fosamax linked to heart problem
omen who have used Fosamax are nearly twice as likely to develop the most common kind of chronically irregular heartbeat (atrial fibrillation) than are those who have never used it, according to research from Group Health and the University of Washington published in the April 28 Archives of Internal Medicine.

Clumps of red and white blood cells may contribute to sickle cell disease
It's long been known that patients with sickle cell disease have malformed, "sickle-shaped" red blood cells - which are normally disc-shaped - that can cause sudden painful episodes when they block small blood vessels.

Key Found to Breakthrough Drug for Clot Victims
A team of researchers at Oregon Health & Science University and Washington University in St. Louis have described for the first time the mechanism that gives a mutant enzyme molecule that they have engineered - and patented - the potential to become a breakthrough drug for treating heart attacks and strokes.

Potentially Safe and Effective Therapy Revealed for Patients with Protein-Losing Enteropathy
Researchers at the Burnham Institute for Medical Research (Burnham Institute) have developed the first model to study intestinal protein leakage in mice, allowing the team to control and replicate both genetic deficiencies and environmental damages in an in vivo setting.
More Anticoagulant News Articles
Managing Anticoagulation Patients in the Hospital: The Inpatient Anticoagulation Service
by Michael Gulseth

The first guide to providing systematic anticoagulation care in inpatient settings, this new resource will be welcomed by all pharmacists who practice in or are developing, implementing and maintaining an inpatient anticoagulation service; a review of anticoagulant medications and case examples of issues commonly encountered. Each chapter contains tools, references, policies, competency...



Phlebotomy: Procedures and Practices
by Lynn B. Hoeltke

Concise and applied, this handbook focuses strictly on learning phlebotomy skills. Phlebotomy: Procedures and Practices is written for those who are already working in health care or who are taking related health courses and have an understanding of basic concepts. Through clearly presented explanations and illustrated step-by-step procedures this handbook provides the information needed to...



Thrombosis & Bleeding: An Era of Discovery
by Cecil Hougie M.D.

This book is for all those that wish to learn the basic facts about the clotting of blood and its...



Consultative Hemostasis and Thrombosis
by Craig S. Kitchens, Barbara M. Alving, Craig M. Kessler, Shearer, Edith J. Applegate

This practical new resource helps readers manage the full range of clotting and bleeding disorders quickly and effectively. Written by a team of respected clinicians, it examines symptoms, laboratory findings, diagnosis, differential diagnosis, and treatment. A reader-friendly design and hundreds of illustrations make it an essential tool for busy physicians.The first strictly clinical resource...

Preventing Ischemic Stroke After Prior Stroke or TIA.(Brief Article)(Statistical Data Included): An article from: Family Practice News
by Mary Ann Moon

This digital document is an article from Family Practice News, published by International Medical News Group on January 15, 2000. The length of the article is 583 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

Oral Anticoagulation: Easy on the Vitamin K.(Statistical Data Included): An article from: Family Practice News
by Bruce Jancin

This digital document is an article from Family Practice News, published by International Medical News Group on April 1, 2000. The length of the article is 678 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

Thrombosis in Cardiovascular Disorders
by Valentin Fuster, Marc Verstraete



Manual of Coagulation Disorders
by Michael H. Kroll, E. Taylor, M. Rutter, Morton N. Swartz, Jack S. Remington, Rothman, St. John, Cody, Carol B. Benson, Steven R. Goldstein, J. David Abrams

Manual of Coagulation Disorders disills the most clinically relevant material from the more conventional reference books. Physicians and trainees who treat thrombotic and hermorrhagic disorders will discover new insight into human diseases caused by thrombosis and bleeding.To provide comprehensive coverage, the author begins with a brief discussion of mechanisms of coagulation, venous and...

Handbook of Compounds with Anti-Inflammatory and Anti-Platelet Aggregation Activities Isolated from Plants
by Rosa Martha Perez Gutierrez

Comparing antithrombotic drugs: aspirin linked to more hospitalization for worsening CHF.(Cardiovascular Medicine): An article from: Internal Medicine News
by Mitchel L. Zoler

This digital document is an article from Internal Medicine News, published by International Medical News Group on April 15, 2004. The length of the article is 782 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

© 2008 BrightSurf.com